Bausch Health Companies
BHC • NYSE
Bausch Health Companies is a drug manufacturers - specialty & generic company in the healthcare sector trading on NYSE, led by CEO Thomas J. Appio, with a market cap of $1.9B.
CEOThomas J. Appio
Market Cap$1.9B
Drug Manufacturers - Specialty & Generic
Healthcare
Employees20.3K
Websitebauschhealth.com
Next Earnings
Upcoming earnings announcement for Bausch Health Companies
Date
Wednesday, April 29, 2026 (in 4 weeks)
Timing
After Market Close (4:05 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.74
Revenue Estimate
$2.4B
Earnings History
Past 12 earnings reports for Bausch Health Companies
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 18, 2026 | Q4 2025 | $1.10Est: $1.24 | -11.3% | $2.8BEst: $2.7B | +3.4% | — |
| Oct 29, 2025 | Q3 2025 | $1.16Est: $1.06 | +9.4% | $2.7BEst: $2.6B | +2.5% |  10-Q |
| Jul 30, 2025 | Q2 2025 | $0.91Est: $0.95 | -4.2% | $2.5BEst: $2.5B | +2.2% | 10-Q |
| Apr 30, 2025 | Q1 2025 | $0.61Est: $0.85 | -28.2% | $2.3BEst: $2.3B | -1.4% | 10-Q |
| Feb 19, 2025 | Q4 2024 | $1.17Est: $1.19 | -1.7% | $2.6BEst: $2.5B | +1.4% | 10-K |
| Oct 30, 2024 | Q3 2024 | $1.12Est: $1.02 | +9.8% | $2.5BEst: $2.4B | +3.7% | 10-Q |
| Aug 1, 2024 | Q2 2024 | $0.98Est: $0.88 | +11.4% | $2.4BEst: $2.3B | +2.7% | 10-Q |
| May 2, 2024 | Q1 2024 | $0.59Est: $0.72 | -18.1% | $2.2BEst: $2.2B | -0.3% | 10-Q |
| Feb 22, 2024 | Q4 2023 | $1.15Est: $1.02 | +12.7% | $2.4BEst: $2.3B | +4.7% | 10-K |
| Nov 2, 2023 | Q3 2023 | $1.03Est: $0.90 | +14.4% | $2.2BEst: $2.2B | +4.0% | — |
| Aug 3, 2023 | Q2 2023 | $0.81Est: $0.75 | +8.0% | $2.2BEst: $2.0B | +6.2% | 10-Q |
| May 4, 2023 | Q1 2023 | $0.52Est: $0.72 | -27.8% | $1.9BEst: $2.0B | -1.3% | 10-Q |